Iowa House Votes to Criminalize Kratom, Sending Shockwaves Through the Industry

Iowa House Votes to Criminalize Kratom, Sending Shockwaves Through the Industry

DES MOINES, IA – March 23, 2026 – The kratom industry is on high alert following a pivotal vote in the Iowa House of Representatives on March 18, 2026, to classify kratom as a Schedule I controlled substance. House File 2133, which passed with a 69-26 vote, would criminalize the possession of kratom and its synthetic equivalents, marking a significant step towards a statewide ban. The bill now proceeds to the Iowa Senate for consideration.

What Happened

Currently legal in Iowa and readily available in vape shops and other retail outlets, kratom faces a potential future where its possession could lead to severe penalties. Under HF 2133, a first offense for possessing kratom would be a serious misdemeanor, punishable by up to a year in jail and a fine of up to $2,560. Subsequent convictions would escalate to aggravated misdemeanors and then Class D felonies. This legislative action follows the rejection of an amendment that sought to regulate kratom rather than prohibit it, a move favored by many advocates for consumer safety and responsible access.

Why It Matters to Kratom Merchants and Consumers

This development carries profound implications for both kratom merchants and consumers in Iowa and could influence legislative efforts nationwide. For Iowa's kratom businesses, the passage of HF 2133 by the Senate would necessitate an immediate cessation of all sales, distribution, and possession of kratom products within the state, effectively dismantling a legal market. Consumers who rely on kratom for its purported mood-lifting, energy-boosting, or pain-relief properties, or as a remedy for opioid withdrawal, would find their access criminalized. Critics of the ban argue that such a prohibition could inadvertently drive the market underground, exposing consumers to unregulated and potentially dangerous products.

Beyond Iowa's borders, this vote serves as a critical indicator of the ongoing struggle between prohibition and regulation. Other states often monitor such legislative outcomes, and Iowa's decision could embolden similar prohibitionist efforts or, conversely, underscore the urgency for proactive regulatory frameworks like the Kratom Consumer Protection Act (KCPA) in states where kratom remains legal.

Compliance Implications and What High-Risk Merchants Need to Know

Should HF 2133 become law, the concept of "compliance" for kratom merchants in Iowa would cease to exist, as the substance would be illegal. For high-risk merchants operating in states where kratom remains legal or is under a regulatory framework, the Iowa situation highlights the volatile landscape and the critical importance of stringent compliance measures.

High-risk merchants must prioritize robust practices around Certificates of Analysis (COAs) and lab testing. These are not merely good business practices but essential safeguards in an evolving regulatory environment:

• Comprehensive Lab Testing: Partner with accredited, third-party laboratories (ideally ISO/IEC 17025:2017 certified) to conduct thorough testing on every batch of kratom. This testing should cover:
  • Alkaloid Content: Confirming levels of key alkaloids like Mitragynine and 7-hydroxymitragynine, ensuring they are within any established limits.
  • Contaminants: Screening for heavy metals (e.g., arsenic, cadmium, lead, mercury), microbial contaminants (e.g., Salmonella, E. coli, yeast, mold), pesticides, and residual solvents.
  • Purity: Verifying the absence of controlled substances or other adulterants.
• Transparent COAs: Ensure COAs are readily available to consumers and clearly display the batch/lot number (matching the product), testing dates, methods of analysis, and the names and addresses of both the manufacturer and the testing laboratory.
• Adherence to Regulatory Standards: In states with KCPAs or similar regulations, merchants must strictly adhere to requirements such as age restrictions (typically 21+), accurate and compliant labeling (avoiding unverified claims or marketing to minors), and product registration with state authorities.

The Iowa House's vote is a stark reminder of the precarious legal status of kratom in many areas. For high-risk merchants, proactive and transparent compliance, anchored by rigorous lab testing and COAs, is not just about meeting current standards but also about building consumer trust and advocating for responsible regulation in an industry constantly under scrutiny.